可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Grover GJ , Mc Cullough JR, Henry DE, et al. Anti-ischemic effects of the potassium channel activators pinacidil and CROMAKALIM and the reversal of the effects with the potassium channel blocker glyburide [J]. J Pharmacol Exp Ther, 1989, 251: 98.
[2] Hirata Y,Aisaka K. Effect of JTV-2506, a novel vasodilator, on coronary blood flow in concious dogs[J]. Am J Physiol, 1991,
261: H2082.
[3] Samaha FF, Heineman FW , Ince C, et al. ATP-sensitive potassium channel is essential to maintain coronary vascular tone in vivo[J]. Am J Phy siol, 1992, 262: C1220.
[4] Ohta H, Jinno Y, Harad K, et al. Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heart [J]. Eur J Pharmacol, 1991, 204: 171.
[5] Nakaya H, Takeda Y, Tohse N , et al. Effects of ATP-sensitive K+ channel blockers on the action potential shortening in hypoxic and ischemic myocardium [J]. Br J Pharmacol, 1991,103: 1019.
[6] Lopez JR, Ghanbari RA , Terzic A. A KATP channel opener protects cardiomyocytes from Ca2+ waves: a laser confocal microscopy study[J]. Am J Physiol, 1996, 270: H1384.
[7] Shigematsu S, Sato T, Abe T, et al. Pharmacological evidence for the persistent activation of ATP-sensitive K+ channels in early phase of reperfusion and its protective role against myocardial stunning[J]. Circulation, 1995, 92: 2266.
[8]McPherson CD, Pierce GN , Cole WC. Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation[J]. Am J Physiol, 1993, 265: H1809.